Iqvia (IQV) Holdings announced that its board authorized the repurchase of an additional $2B of Iqvia’s common stock under Iqvia’s existing equity repurchase program, bringing the total remaining authorization to $3.2B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia price target lowered to $225 from $240 at Morgan Stanley
- IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210
- IQVIA: Buy Rating Reiterated on Solid Growth and Valuation, $240 Price Target Unchanged
- IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook
- IQVIA Holdings Earnings Call Highlights Growth And AI